Italy Drug Delivery Devices Market Size
| Study Period | 2019 - 2029 |
| Base Year For Estimation | 2023 |
| Forecast Data Period | 2024 - 2029 |
| Historical Data Period | 2019 - 2022 |
| CAGR | 22.40 % |
Major Players
*Disclaimer: Major Players sorted in no particular order |
Need a report that reflects how COVID-19 has impacted this market and its growth?
Italy Drug Delivery Devices Market Analysis
The Italian drug delivery devices market is expected to register a CAGR of 22.4% over the forecast period.
- The Italian drug delivery devices market has been significantly impacted by the COVID-19 pandemic because of the development of COVID-19 vaccinations and treatments, which has raised the market's need for needles and syringes for drug delivery devices. For instance, in September 2022, the distribution of Moderna and Pfizer-BioNTech COVID-19 vaccines designed to stop the spread of the Omicron version of the virus was approved by AIFA in Italy.
- The rising prevalence of chronic diseases and the development of new drugs and biologics are key factors driving the Italian drug delivery devices market growth. Drug delivery devices deliver the drugs that are beneficial for the targeted population to recover fasUsingage of these drug delivery devices reduces the chances of side effects by improving the drug present at the target site. This helps in reducing the dose and associated side effects.
- In addition, a rising number of chronic diseases like diabetes across the region will promote the adoption of drug-delivery devices and drive the overall market. As per IDF Diabetes Atlas, 2021, the age-adjusted comparative prevalence of diabetes in Italy was estimated as 6.4%, 7.4%, and 8.0% for 2021, 2030, and 2045, respectively. The presence of a huge target population will require regular drug delivery devices for diagnosis and treatment purposes and propel the drug delivery devices market. Similarly, the rising burden of chronic diseases increases the demand for targeted therapy, which is majorly administered through the injectable route of administration. Moreover, increasing R&D expenditure by innovators and market players and technological advancements in understanding human biology and diseases will fuel the overall market.
- However, the risk of needlestick injuries is restraining the growth of the Italian drug delivery devices market.
Italy Drug Delivery Devices Market Trends
This section covers the major market trends shaping the Italy Drug Delivery Devices Market according to our research experts:
Injectable Under Route of Administration is Estimated to Witness Healthy Growth Over the Forecast Period
An injection is an act of administering a liquid, especially a drug, into a person's body using a needle and a syringe. The primary purpose of injectable drug delivery is to get an immediate onset of action of the drug and for direct administration of the drug to the systemic circulation. The primary factor attributed to the high growth of the injectable drug delivery device segment is the growing burden of chronic disease and the convenience associated with the device.
The new developments in the region's prevention and treatment of chronic diseases drive the market over the forecast period. For instance, as per the ANSA Corporate, in August 2022, an Italian research team created a cancer vaccine that can stimulate immune responses against tumors and improve the efficiency of immunotherapy medications. The vaccine uses a virus as a trojan horse. Thus, the new vaccine developments need injectable drug delivery devices to administer and are expected to positively impact the market over the forecast period.
Similarly, advanced drug delivery devices among the injectable segment and the collaborations of major players are expected to impact the market over the forecast period positively. For instance, in April 2022, Italian-based Stevanato Group SpA and Bexson Biomedical Inc. signed an agreement expanding their collaboration that would grant Bexson access to the use of Stevanato's wearable delivery system a customized version of the SG EZ-be Pod. SG EZ-be Pod is a small, wearable subcutaneous drug delivery device that can be programmed for a wide range of medications and delivery profiles, including at-home delivery.
Thus, due to the aforementioned factors, the administration segment's injectable route is expected to grow significantly over the forecast period.
Infectious Diseases Under Application is Estimated to Witness Highest CAGR Over the Forecast Period
Infectious diseases are disorders caused by organisms such as bacteria, viruses, fungi, or parasites. The increasing burden of infectious diseases like HIV, shingles, tuberculosis, and others in Italy increases the demand for treatment using various drug-delivery devices and drives the market over the study period.
For instance, as per the report published by Beyond Rheumatology in July 2022, the yearly incidence of shingles (Herpes Zoster) in those under 50 years old in Italy is 6.46 cases per 1,000 person-years. Herpes Zoster incidence rises with age. Also, given that varicella-zoster virus infection puts 90% of adults at risk for getting shingles, the disease affects at least 1 in 3 people throughout their lifetimes. Hence with the increasing burden of infections, preventive measures should be taken through vaccinations using various injectable drug delivery devices that may drive the segment growth over the study period.
Furthermore, as per the report published by Human Vaccines & Immunotherapeutics in September 2021, the recombinant zoster vaccine is preferable over the zoster live vaccine for the prevention of herpes zoster (HZ) and associated problems. Moreover, as reported in the Ministerial Circular dated March 2021, a new recombinant adjuvanted -RZV vaccine against HZ is available in Italy through the public channel. Hence novel and advanced preventive options for infectious diseases using vaccination increase the usage of injectable drug delivery devices, which is expected to boost the segment growth over the forecast period in the country.
Italy Drug Delivery Devices Industry Overview
The Italian drug delivery devices market is moderately competitive and consists of several major players. Some of the companies currently dominating the market are Pfizer Inc., Novartis AG, F. Hoffmann-La Roche Ltd, Johnson & Johnson Services Inc., Gerresheimer AG, BD (Becton, Dickinson, and Company), Baxter, Teva Pharmaceutical Industries Ltd, and Viatris Inc.
Italy Drug Delivery Devices Market Leaders
-
Gerresheimer AG
-
Teva Pharmaceutical Industries Ltd
-
Viatris Inc
-
Baxter
-
BD (Becton, Dickinson and Company)
*Disclaimer: Major Players sorted in no particular order
Italy Drug Delivery Devices Market News
- In September 2022, Stevanato Group SpA and Gerresheimer AG jointly developed a high-end Ready-To-Use (RTU) solution platform with an initial focus on vials based on Stevanato Group's market-leading EZ-fill technology.
- In May 2022, Stevanato Group SpA, an Italian multinational company, signed an exclusive agreement with leading medical device developer and manufacturer Owen Mumford Ltd for its Aidaptus auto-injector. The agreement makes Stevanato Group an exclusive manufacturing partner for the device, offering a full set of capabilities to its pharmaceutical customers.
Italy Drug Delivery Devices Market Report - Table of Contents
1. INTRODUCTION
- 1.1 Study Assumptions and Market Definition
- 1.2 Scope of the Study
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
- 4.1 Market Overview
-
4.2 Market Drivers
- 4.2.1 Rising Prevalence of Chronic Diseases
- 4.2.2 Technological Advancements Coupled with Rapidly Growing Biologics Market
-
4.3 Market Restraints
- 4.3.1 Risk of Needlestick Injuries
-
4.4 Porter's Five Forces Analysis
- 4.4.1 Threat of New Entrants
- 4.4.2 Bargaining Power of Buyers/Consumers
- 4.4.3 Bargaining Power of Suppliers
- 4.4.4 Threat of Substitute Products
- 4.4.5 Intensity of Competitive Rivalry
5. MARKET SEGMENTATION (Market Size by Value - USD million)
-
5.1 By Route of Administration
- 5.1.1 Injectable
- 5.1.2 Topical
- 5.1.3 Ocular
- 5.1.4 Other Routes of Administration
-
5.2 By Application
- 5.2.1 Cancer
- 5.2.2 Cardiovascular
- 5.2.3 Diabetes
- 5.2.4 Infectious Diseases
- 5.2.5 Other Applications
-
5.3 By End User
- 5.3.1 Hospitals
- 5.3.2 Ambulatory Surgical Centers
- 5.3.3 Other End Users
6. COMPETITIVE LANDSCAPE
-
6.1 Company Profiles
- 6.1.1 Pfizer Inc.
- 6.1.2 Novartis AG
- 6.1.3 F. Hoffmann-La Roche Ltd
- 6.1.4 Johnson & Johnson Services Inc.
- 6.1.5 Gerresheimer AG
- 6.1.6 BD (Becton, Dickinson and Company)
- 6.1.7 Baxter
- 6.1.8 Teva Pharmaceutical Industries Ltd
- 6.1.9 Viatris Inc.
- *List Not Exhaustive
7. MARKET OPPORTUNITIES AND FUTURE TRENDS
** Subject To AvailablityItaly Drug Delivery Devices Industry Segmentation
As specified in the scope, drug delivery devices or systems are the tools used to deliver the drug through the specific route of administration. It enables the introduction of therapeutic substances in the body.
The Italian drug delivery devices market is expected to register a CAGR of 22.4% over the forecast period. The Italian drug delivery devices market is segmented by route of administration (injectable, topical, ocular, and other routes of administration), application (cancer, cardiovascular, diabetes, infectious diseases, and other applications), and end user (hospitals, ambulatory surgical centers, and other end users). The report offers the value (in USD million) for the above segments.
| By Route of Administration | Injectable |
| Topical | |
| Ocular | |
| Other Routes of Administration | |
| By Application | Cancer |
| Cardiovascular | |
| Diabetes | |
| Infectious Diseases | |
| Other Applications | |
| By End User | Hospitals |
| Ambulatory Surgical Centers | |
| Other End Users |
Italy Drug Delivery Devices Market Research FAQs
What is the current Italy Drug Delivery Devices Market size?
The Italy Drug Delivery Devices Market is projected to register a CAGR of 22.40% during the forecast period (2024-2029)
Who are the key players in Italy Drug Delivery Devices Market?
Gerresheimer AG, Teva Pharmaceutical Industries Ltd, Viatris Inc, Baxter and BD (Becton, Dickinson and Company) are the major companies operating in the Italy Drug Delivery Devices Market.
What years does this Italy Drug Delivery Devices Market cover?
The report covers the Italy Drug Delivery Devices Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Italy Drug Delivery Devices Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029.
Italy Drug Delivery Devices Industry Report
Statistics for the 2024 Italy Drug Delivery Devices market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Italy Drug Delivery Devices analysis includes a market forecast outlook to 2029 and historical overview. Get a sample of this industry analysis as a free report PDF download.
